Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 17, 2021
Efficacy and safety of netupitant/palonosetron combination (NEPA) in preventing nausea and vomiting in non-Hodgkin's lymphoma patients undergoing to chemomobilization before autologous stem cell transplantationNicola Di Renzo, Maurizio Musso, Rosanna Scimè, et al.
BMC Cancer|April 27, 2025
Autologous stem cell transplantation for adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. A study by the Acute Leukemia Working Party of the EBMTRyszard Swoboda, Myriam Labopin, Sebastian Giebel, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 26, 2015
Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC)Salvatore Giacomo Morano, Roberto Latagliata, Corrado Girmenia, et al.
The Oncologist|March 10, 2026
Long-Term Health-Related Quality of Life and Lifestyle Behavior of Patients with Acute Myeloid LeukemiaFabio Efficace, Laura Cannella, Xavier Thomas, et al.
Blood Advances|November 3, 2021
ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocolFrancesco Buccisano, Raffaele Palmieri, Alfonso Piciocchi, et al.
Bone Marrow Transplantation|January 14, 2018
Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) scoreJacopo Olivieri, Immacolata Attolico, Roberta Nuccorini, et al.
Blood Cancer Journal|July 5, 2024
Hematopoietic stem cell transplantation for DLBCL: a report from the European Society for Blood and Marrow Transplantation on more than 40,000 patients over 32 yearsPhilipp Berning, Mathilde Fekom, Maud Ngoya, et al.
Blood Advances|March 6, 2025
Safety run-in and part 1 of GIMEMA AML1718: venetoclax combined with FLAI as induction treatment in non-low-risk AMLGiovanni Marconi, Alfonso Piciocchi, Ernesta Audisio, et al.
Journal of Clinical Medicine|October 24, 2020
The HLA Variant rs6903608 Is Associated with Disease Onset and Relapse of Immune-Mediated Thrombotic Thrombocytopenic Purpura in CaucasiansIlaria Mancini, Elisa Giacomini, Silvia Pontiggia, et al.
Haematologica|May 30, 2020
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913Sabina Chiaretti, Monica Messina, Irene Della Starza, et al.
Pageof 6